Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer

Masafumi Yamaguchi, Kenji Sugio, Kaoru Ondo, +2

Lung Cancer

OncologyThrombospondin-1 CorrelatesMedicineImmunologyPathology +5

Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and β-catenin: Risk assessment by immunohistochemistry

Kenji Sugio, Shinichiro Kase, Takashi Sakada, +4

Surgery

Risk AssessmentOncologyMedicinePathologyCancer Cell Biology +7

Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer

Tokujiro Yano, Kenji Sugio, Koji Yamazaki, +5

Lung Cancer

Cancer ImmunosurveillanceCell Lung CancerPathologic StageMedicineImmunology +9

Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey.

Ryuichi Suemitsu, Masafumi Yamaguchi, Sadanori Takeo, +4

PubMed

Expression of E-cadherin and beta-catenin in human non-small cell lung cancer: Clinical significance and prognosis

Shinichiro Kase, Kenji Sugio, Koji Yamazaki, +6

Lung Cancer

Tumor BiologyOncologyMedicinePathologyBronchial Neoplasm +5

Cystic Schwannoma Presenting as Massive Hemoptysis in an Adult

Kaoru Ondo, Kenji Sugio, Tokujiro Yano, +4

Respiration

Neurological DisorderDiagnosisPathologyPleural EffusionInterventional Radiology +17

Thymoma arising in a thymic cyst.

Kenji Sugio, Kaoru Ondo, Masayoshi Yamaguchi, +4

PubMed

Cyst WallEar MoldingSurgical PathologyHistopathologyPathology +4

LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma

Atsushi Osoegawa, Takuro Kometani, Kaname Nosaki, +6

Japanese Journal of Clinical Oncology

The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer

Kaoru Ondo, Kenji Sugio, Koji Yamazaki, +4

Lung Cancer

Tumor BiologyCancer DetectionMedicinePathologyBronchial Neoplasm +6

Concurrent chemoradiotherapy using cisplatin plus s-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: A single-center feasibility study

Riichiroh Maruyama, Fumihiko Hirai, Kaoru Ondo, +5

Surgery Today

Oral FluoropyrimidineConcurrent ChemoradiotherapySurgical OncologyRadiation TherapyMedicine +8